DEVESH VYAS, MD
Ophthalmology Physician in BELLFLOWER, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
DEVESH VYAS, MD reported a CMS MIPS final score of 78.8552/100 — below the 83.1 national average — and filed 926 Medicare Part D claims in 2023.
- 78.8552/100
- MIPS score · -4 vs avg
- 926
- Part D claims, 2023
- 69%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
DEVESH VYAS, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
79 27th percentile higher than 27% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
DEVESH VYAS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about DEVESH VYAS, MD?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Ophthalmology Physician compares to other specialties among California providers
Ophthalmology Physician share within California
Ophthalmology Physician is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
DEVESH VYAS, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 78.8552/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) — 78.8552/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Ophthalmology Physician US NPIs
78.8552/100 MIPS final score — 4.2 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 66.6851. Cost dim: 54.8733.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
DEVESH VYAS, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 9400 ROSECRANS AVE, BELLFLOWER, CA, 90706, with a listed phone of (562) 461-3000. NPI 1154446664 was issued on 03/21/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what VYAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 926 prescription claims written by this provider, covering 375 Medicare beneficiaries and totaling roughly $40K in drug spend, split 31% brand-name and 69% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 78.8552/100 for the 2023 performance year (Quality 66.6851, Cost 54.8733), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1154446664 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 03/21/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm DEVESH VYAS, MD's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to DEVESH VYAS, MD. To verify DEVESH VYAS, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
31% brand-name claims vs 69% generic, on 926 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,807
- Total Day Supply
- 49,656
- Brand vs Generic
- 31% brand / 69% generic
- Brand Drug Cost
- $23K
- Generic Drug Cost
- $17K
Patient Demographics
- Average Patient Age
- 77.0 years
- Avg HCC Risk Score
- 1.24
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 13, 65-74: 146, 75-84: 143, 85+: 73
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What DEVESH VYAS, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisolone Acetate
Prednisolone Acetate
239 claims
- Latanoprost
Latanoprost
211 claims
- Moxifloxacin
Moxifloxacin
143 claims
- Brimonidine Tartrate
Brimonidine Tartrate
99 claims
- Timolol Maleate 66
Timolol Maleate
66 claims
- Cyclopentolate Hcl 50
Cyclopentolate Hcl
50 claims
- Dorzolamide-Timolol 32
Dorzolamide-Timolol
32 claims
- Ofloxacin 19
Ofloxacin
19 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 239 |
| Latanoprost | 211 |
| Moxifloxacin Moxifloxacin Hcl | 143 |
| Brimonidine Tartrate | 99 |
| Timolol Maleate | 66 |
| Cyclopentolate Hcl | 50 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 32 |
| Ofloxacin | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How DEVESH VYAS, MD fits within the Ophthalmology Physician landscape nationally.
DEVESH VYAS, MD's 926 claims are below the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as VYAS.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is DEVESH VYAS, MD's specialty? ▼
How much does DEVESH VYAS, MD prescribe under Medicare Part D? ▼
What is DEVESH VYAS, MD's Medicare quality score? ▼
Where is DEVESH VYAS, MD located? ▼
What is DEVESH VYAS, MD's NPI number? ▼
Does DEVESH VYAS, MD prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does DEVESH VYAS, MD prescribe most often? ▼
Does DEVESH VYAS, MD accept Medicare? ▼
How can I verify DEVESH VYAS, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology